What is remission? What does it mean?

What other supportive therapies may I be receiving in addition to the CLL treatment?
Why may real world data not always reflect what was learned in a clinical trial?
Which treatments are given in the hospital and which are given in a clinic?
When should a patient consider changing therapy?
How can real world evidence lead to FDA label changes?
How do I know if I am responding to treatment? What tests are used to determine a response?
What is the difference between chemotherapy and targeted therapy?
How can real world data be used to guide treatment decision making?